高级检索
当前位置: 首页 > 详情页

The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-beta/Smad3-Azin1 pathway

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China [2]Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, China [3]Department of Nephrology, First People’s Hospital of Yunnan Province, Yunnan, China [4]Shenzhen Research Institute, CUHK, Shenzhen, China [5]Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China
出处:
ISSN:

关键词: microRNA therapy miR-433 renal fibrosis TGF-beta signaling

摘要:
The TGF-beta/Smad3 pathway plays a major role in tissue fibrosis, but the precise mechanisms are not fully understood. Here we identified microRNA miR-433 as an important component of TGF-beta/Smad3-driven renal fibrosis. The miR-433 was upregulated following unilateral ureteral obstruction, a model of aggressive renal fibrosis. In vitro, overexpression of miR-433 enhanced TGF-beta 1-induced fibrosis, whereas knockdown of miR-433 suppressed this response. Furthermore, Smad3, but not Smad2, bound to the miR-433 promoter to induce its expression. Delivery of an miR-433 knockdown plasmid to the kidney by ultrasound microbubble-mediated gene transfer suppressed the induction and progression of fibrosis in the obstruction model. The antizyme inhibitor Azin1, an important regulator of polyamine synthesis, was identified as a target of miR-433. Overexpression of miR-433 suppressed Azin1 expression, while, in turn, Azin1 overexpression suppressed TGF-beta signaling and the fibrotic response. Thus, miR-433 is an important component of TGF-beta/Smad3-induced renal fibrosis through the induction of a positive feedback loop to amplify TGF-beta/Smad3 signaling, and may be a potential therapeutic target in tissue fibrosis.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2013]版:
大类 | 1 区 医学
小类 | 1 区 泌尿学与肾脏学
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 泌尿学与肾脏学
JCR分区:
出版当年[2012]版:
Q1 UROLOGY & NEPHROLOGY
最新[2023]版:
Q1 UROLOGY & NEPHROLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2012版] 出版当年五年平均 出版前一年[2011版] 出版后一年[2013版]

第一作者:
第一作者机构: [1]Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China [2]Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, China [3]Department of Nephrology, First People’s Hospital of Yunnan Province, Yunnan, China
共同第一作者:
通讯作者:
通讯机构: [1]Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China [4]Shenzhen Research Institute, CUHK, Shenzhen, China [*1]Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82490 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号